Champlain Investment Partners LLC Increases Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Champlain Investment Partners LLC boosted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 8.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,818,345 shares of the medical device company’s stock after acquiring an additional 134,875 shares during the period. Champlain Investment Partners LLC owned 0.91% of Cooper Companies worth $200,636,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Janus Henderson Group PLC boosted its position in shares of Cooper Companies by 279.8% during the 1st quarter. Janus Henderson Group PLC now owns 3,437,064 shares of the medical device company’s stock valued at $348,723,000 after acquiring an additional 2,532,186 shares during the last quarter. Swedbank AB purchased a new stake in Cooper Companies in the first quarter valued at approximately $139,246,000. Point72 Asset Management L.P. lifted its position in Cooper Companies by 480.1% during the second quarter. Point72 Asset Management L.P. now owns 937,806 shares of the medical device company’s stock valued at $81,870,000 after purchasing an additional 776,140 shares during the last quarter. Victory Capital Management Inc. grew its stake in Cooper Companies by 23.0% in the 3rd quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock worth $435,856,000 after buying an additional 737,726 shares in the last quarter. Finally, Magnetar Financial LLC purchased a new stake in shares of Cooper Companies during the 2nd quarter valued at $63,822,000. Institutional investors own 24.39% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on COO shares. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Thursday, August 29th. Wells Fargo & Company boosted their target price on Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a research report on Thursday, August 29th. StockNews.com cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday. Robert W. Baird boosted their price objective on shares of Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a report on Thursday, August 29th. Finally, Morgan Stanley upped their price objective on shares of Cooper Companies from $95.00 to $104.00 and gave the company an “equal weight” rating in a research note on Tuesday, September 10th. Four research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $117.00.

Cooper Companies Price Performance

Shares of Cooper Companies stock opened at $100.80 on Friday. The firm has a market cap of $20.08 billion, a PE ratio of 56.16, a price-to-earnings-growth ratio of 2.15 and a beta of 0.99. The company’s fifty day simple moving average is $105.91 and its two-hundred day simple moving average is $98.26. The company has a quick ratio of 1.18, a current ratio of 1.99 and a debt-to-equity ratio of 0.33. The Cooper Companies, Inc. has a 12-month low of $82.21 and a 12-month high of $112.38.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.05. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The company had revenue of $1 billion for the quarter, compared to the consensus estimate of $997.30 million. During the same quarter in the previous year, the business earned $0.84 EPS. Cooper Companies’s revenue was up 7.8% compared to the same quarter last year. As a group, equities analysts expect that The Cooper Companies, Inc. will post 3.65 EPS for the current year.

Insider Buying and Selling

In related news, CEO Albert G. White III sold 114,992 shares of Cooper Companies stock in a transaction that occurred on Thursday, September 19th. The stock was sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the sale, the chief executive officer now directly owns 165,273 shares in the company, valued at $18,267,624.69. The trade was a 41.03 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CAO Agostino Ricupati sold 1,601 shares of the company’s stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $108.03, for a total value of $172,956.03. Following the completion of the sale, the chief accounting officer now directly owns 4,818 shares in the company, valued at approximately $520,488.54. The trade was a 24.94 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 256,373 shares of company stock valued at $27,637,427 over the last quarter. 2.00% of the stock is owned by company insiders.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.